oxaliplatin
Showing 26 - 50 of 922
Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)
Terminated
- Colorectal Neoplasms
- bevacizumab
- +3 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Dec 30, 2021
Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)
Recruiting
- Colorectal Cancer Metastatic
- Dexamethasone
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 3, 2023
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair Trial in China (S1,
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- S1
- +3 more
-
Hangzhou, Zhejiang, China
- +4 more
May 23, 2023
Lung Metastases, Colorectal Cancer Metastatic, Colorectal Cancer Trial (Oxaliplatin)
Not yet recruiting
- Lung Metastases
- +2 more
- Oxaliplatin
- (no location specified)
Nov 3, 2022
Non-hodgkin Lymphoma,B Cell, Refractory DLBCL, Relapsed DLBCL Trial in United States (MT-3724, Gemcitabine, Oxaliplatin)
Terminated
- Non-hodgkin Lymphoma,B Cell
- +2 more
- MT-3724
- +2 more
-
Orange, California
- +8 more
Jul 18, 2022
Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Docetaxel,
Recruiting
- Metastatic Gastric Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Docetaxel
- +2 more
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated hosipital, Sun Yat-Sen University
Jan 20, 2022
Gastric Cancer, GastroEsophageal Cancer Trial in China (SHR-1210, Capecitabine, Oxaliplatin)
Completed
- Gastric Cancer
- GastroEsophageal Cancer
- SHR-1210
- +3 more
-
Hefei, Anhui, China
- +9 more
Jun 30, 2022
Pancreas Cancer, Adenocarcinoma of the Pancreas Trial in Omaha (Digoxin, 5Fluorouracil, Calcium Leucovorin)
Recruiting
- Pancreas Cancer
- Adenocarcinoma of the Pancreas
- Digoxin
- +4 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Mar 31, 2022
Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With
Enrolling by invitation
- Gastric Cancer
- Gastrectomy
- +3 more
-
Shanghai, Shanghai, ChinaZhongshan hospital
May 1, 2022
Early Low Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)
Recruiting
- Early Low Rectal Cancer
- PD-1 antibody
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 9, 2023
Metastatic Colorectal Cancer Trial in Herlev (Oxaliplatin, 5-Fluorouracil, Leucovorin)
Withdrawn
- Metastatic Colorectal Cancer
- Oxaliplatin
- +4 more
-
Herlev, DenmarkHerlev University Hospital, Department of Oncology
Oct 19, 2021
Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles
Active, not recruiting
- Mucinous Adenocarcinoma of the Rectum
- +7 more
- bevacizumab
- +4 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Aug 5, 2022
Locally Advanced Colon Cancer Trial (Serplulimab, short-term radiotherapy, Oxaliplatin)
Not yet recruiting
- Locally Advanced Colon Cancer
- Serplulimab
- +3 more
- (no location specified)
Feb 16, 2023
Gastric Adenocarcinoma, Esophagus Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in France
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- Trifluridine/Tipiracil
- +2 more
-
Amiens, France
- +20 more
Jul 26, 2022
Colorectal Adenocarcinoma, Oesogastric Trial in France (Trifluridine/Tipiracil, Oxaliplatin)
Recruiting
- Colorectal Adenocarcinoma
- Oesogastric
- Trifluridine/Tipiracil
- Oxaliplatin
-
Besançon, France
- +10 more
Jan 28, 2022
Colorectal Cancer, Peritoneal Metastases Trial in Sweden (5Fluorouracil, Irinotecan, Oxaliplatin)
Recruiting
- Colorectal Cancer
- Peritoneal Metastases
- 5Fluorouracil
- +2 more
-
Gothenburg, Sweden
- +3 more
Oct 12, 2021
Gastric Cancer in Situ, Pancreatic Cancers, Biliary Cancers Trial in Taipei (Oxaliplatin, Albumin-Bound Paclitaxel
Completed
- Gastric Cancer in Situ
- +2 more
- Oxaliplatin
- +3 more
-
Taipei, TaiwanTaiwan Cooperative Oncology Group, National Health Research Inst
Apr 5, 2022
Colorectal Carcinoma Trial in Guangzhou (Sintilimab, Oxaliplatin, capecitabine)
Recruiting
- Colorectal Carcinoma
- Sintilimab
- +2 more
-
Guangzhou, ChinaSun Yat-sen University
Dec 29, 2022
Locally Advanced Unresectable Gastric Adenocarcinoma Trial in Tianjin (Oxaliplatin, Capecitabine, Cadonilimab)
Not yet recruiting
- Locally Advanced Unresectable Gastric Adenocarcinoma
- Oxaliplatin
- +2 more
-
Tianjin, Tianjin, ChinaXuewei Ding
Aug 2, 2023
Colorectal Cancer, Appendiceal Cancer, Peritoneal Carcinoma Trial in Salt Lake City (Oxaliplatin, mFOLFIRI)
Terminated
- Colorectal Cancer
- +2 more
- Oxaliplatin
- mFOLFIRI
-
Salt Lake City, UtahHuntsman Cancer Institute
Sep 21, 2021